JEF vs UMBF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JEF presents a stark contrast between deep value and deteriorating operational health, highlighted by a weak Piotroski F-Score of 2/9. While the stock is significantly undervalued relative to its Graham Number ($58.99) and Intrinsic Value ($87.91), and trades below book value (P/B 0.93), the deterministic health metrics are alarming. Strong year-over-year revenue and earnings growth are offset by a bearish technical trend (0/100) and a recent negative Q/Q EPS growth of -27.1%. The investment case relies on a value-recovery thesis, but the operational red flags necessitate a cautious approach.
UMBF presents a compelling value opportunity, trading significantly below its Graham Number ($142.69) and Intrinsic Value ($240.61). While the Piotroski F-Score of 4/9 indicates stable but not exceptional financial health, the company exhibits explosive revenue growth (67.6% YoY) and a consistent track record of earnings beats. Despite bearish insider sentiment and technical trends, the fundamental valuation and low forward P/E (9.42) suggest significant upside potential.
Compare Another Pair
Related Comparisons
JEF vs UMBF: Head-to-Head Comparison
This page compares Jefferies Financial Group Inc. (JEF) and UMB Financial Corporation (UMBF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.